Subsequent literature review proved that Ciclopirox inhibited the growth of glioblastoma cell lines (U251, SF126, A172, and U118) via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling [74]. The gene discussed is NFKB1; the disease is glioblastoma.